Establishment of a highly sensitive assay for detection of Hepatitis E virus-specific immunoglobulins.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractHepatitis E, a liver disease caused by infection with the hepatitis E virus (HEV) is a worldwide emerging disease. The diagnosis is based on the detection of viral RNA and of HEV-specific immunoglobulins (Ig). For the latter, various assays are commercially available but still lack harmonization.In this study, a Luminex®-based multiplex serological assay was established, that measures the presence of total IgG, IgA and IgM antibodies, targeting a short peptide derived from the viral E2 protein. For the validation, 160 serum samples with a known HEV serostatus were used to determine the assay cut-off and accuracy. Thereby, HEV-IgG and -RNA positive sera were identified with a sensitivity of 100% and a specificity of 98% [CI95% 94-100%].Application of the assay by re-testing 514 sera previously characterised with different HEV-IgG or total antibody tests, revealed a high level of agreement between the assays (Cohens Kappa 0.58-0.99).The established method is highly sensitive, specific and can be easily implemented in a multiplex format to facilitate rapid differential diagnostics with a few microliters of sample input.
CitationJ Clin Microbiol. 2019 Nov 6. pii: JCM.01029-19. doi: 10.1128/JCM.01029-19
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
JournalJournal of clinical microbiology
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area.
- Authors: Wu WC, Su CW, Yang JY, Lin SF, Chen JY, Wu JC
- Issue date: 2014 Apr
- Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
- Authors: Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF, Osterhaus AD, van der Eijk AA
- Issue date: 2013 Dec
- Are VIDAS® anti-HEV IgM and IgG assays fit for reliable diagnosis of hepatitis E virus infections? Comparison & case story telling.
- Authors: Cattoir L, Vercauteren KOA, Padalko E, De Beenhouwer H, Van Vaerenbergh K, Boel A
- Issue date: 2021 Feb
- Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.
- Authors: Yu C, Engle RE, Bryan JP, Emerson SU, Purcell RH
- Issue date: 2003 Jul
- Clinical significance of anti-HEV IgA in diagnosis of acute genotype 4 hepatitis E virus infection negative for anti-HEV IgM.
- Authors: Zhang S, Tian D, Zhang Z, Xiong J, Yuan Q, Ge S, Zhang J, Xia N
- Issue date: 2009 Nov